SBFM

Healthcare Drug Manufacturers - Specialty & Generic

Sunshine Biopharma, Inc.

$0.67
-0.03 -4.70% today

Price History

Not enough data

Key Stats

Market Cap
2.87M
Avg Volume
519,771
EPS
-$9.45
52W High
$24.30
52W Low
$0.67
Div. Yield
0.0%

Analyst Ratings

Buy
0
Str Buy
1
Buy
0
Hold
0
Sell
0
Str Sell

Valuation

Forward P/E
0.00
P/B Ratio
0.06
P/S Ratio
0.08
EV/EBITDA
2.22
EV/Revenue
-0.30

Margins

Gross Margin 30.3%
Operating Margin (17.4%)
Net Margin (16.5%)
EBITDA Margin (13.7%)

Growth & Returns

Revenue Growth (YoY)
(1.6%)
Return on Equity
(21.9%)
Return on Assets
(9.9%)

Liquidity & Leverage

Current Ratio
5.46
Quick Ratio
3.21
Debt / Equity
0.02
Total Cash
14.03M
Total Debt
678,338

About

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.

sunshinebiopharma.com